Vote Scores
Filings read through

Perspective Therapeutics, Inc.: how funds voted at the meeting of 27 May 2026

Ticker
CATX
Meeting
Season
year to 30 June 2026
Filers reporting
191
Ballot items
4

191 filers on Form N-PX reported votes at the Perspective Therapeutics, Inc. meeting of 27 May 2026. The records fall into 4 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2026. Filings read through . How the figures are made

The ballot

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

  1. Item 1: Director elections

    6 nominees. 73.1% of the reported votes are for. 48 filers withheld from or voted against at least one nominee.

    702 vote records from 64 filers. 1 of the 64 filers that marked the item voted against management.

    • Positions of 30 fund families
    • For 26
    • Abstain or withhold 1
    • Split or no vote 3
    • Against management 1
  2. Item 2: Advisory vote on executive pay (say-on-pay)

    1 vote record from 1 filer. No filer marked the item for or against management. 1 filer gave no management mark.

  3. Item 3: Frequency of the say-on-pay vote

    One year: 167 filers. Three years: 5 filers. For: 5 filers. Not applicable: 2 filers. Abstain: 2 filers. None: 1 filer.

    273 vote records from 190 filers. 5 of the 176 filers that marked the item voted against management. 14 filers gave no management mark.

    • Positions of 38 fund families
    • For 1
    • Split or no vote 37
    • Against management 2
  4. Item 4: Audit-related items (auditor ratification)

    117 vote records from 64 filers. 0 of the 64 filers that marked the item voted against management.

    • Positions of 30 fund families
    • For 30

Positions of the fund families

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at Perspective Therapeutics, Inc., meeting of 27 May 2026Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund family3. Pay-vote frequency4. Auditor
AllianceBernsteinSplitNo report
American CenturySplitFor
BlackRock and iSharesSplitFor
BNY MellonSplitNo report
Brighthouse FundsForFor
Charles SchwabSplitFor
Columbia ThreadneedleSplitFor
DimensionalSplit, against managementFor
DWSSplitFor
EquitableSplitFor
Federated HermesSplitFor
FidelitySplitFor
First TrustSplitNo report
Global XSplitFor
Goldman SachsSplitFor
Guggenheim and RydexSplitFor
InvescoSplitFor
J.P. MorganSplitNo report
Jackson National fundsSplit, against managementFor
John Hancock and ManulifeSplitFor
Lincoln FinancialSplitFor
Morgan Stanley, Eaton Vance and CalvertSplitFor
NationwideSplitFor
Natixis and Loomis SaylesSplitNo report
Neuberger BermanSplitNo report
Northern Trust and FlexSharesSplitFor
Nuveen and TIAASplitFor
Pacific Life fundsSplitFor
PGIM and PrudentialSplitNo report
PrincipalSplitFor
ProShares and ProFundsSplitFor
Russell InvestmentsSplitNo report
SEISplitFor
State Street and SPDRSplitFor
T. Rowe PriceSplitFor
VanguardSplitFor
Victory CapitalSplitFor
VoyaSplitFor

Questions

How many filers reported votes at the Perspective Therapeutics, Inc. meeting?
191 Form N-PX filers reported votes at the meeting of 27 May 2026.
Is this the result of the meeting?
No. The page counts the filers that report on Form N-PX, and the shares they reported. Perspective Therapeutics, Inc. reports the result of a vote on Form 8-K.
Why does the page show counts only for director elections?
A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Perspective Therapeutics, Inc. with a meeting date within three days of 27 May 2026. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .